Nava

Approach

Nava partnered with Thermal to translate years of platform science into a credible, differentiated debut. Together, we::

• • Defined positioning and messaging: Developed Nava’s core narrative to establish the company as the definitive solution to genetic medicine’s delivery bottleneck, articulating how its proprietary LNP platform enables selective targeting of extrahepatic tissues, unlocking in vivo CAR-T and RNA therapies previously out of reach.
  • Built the Nava brand and launch infrastructure: Developed website copy, narrative architecture, and visual storytelling to make Nava’s complex lipid chemistry accessible to investors, partners, and media.
  • Orchestrated a precision soft-launch strategy: Anchored Nava’s public emergence around two oral presentations at ASGCT 2026 and TIDES 2026, publishing on-site press releases and coordinated social content to establish Nava’s presence in the LNP delivery space while preserving narrative control.
  • Developed executive communications and media readiness: Conducted multiple rounds of media training to sharpen launch narrative, company origin story, and scientific differentiation. Developed comprehensive messaging Q&As and employee social guidance to prepare the entire Nava team for conference interactions and incoming press inquiries during their stealth period.

Impact

Through our partnership, Nava has:

• • Established category presence at two major conferences: Nava’s oral presentations at ASGCT 2026 and TIDES 2026 generated inbounds from key reporters in the gene and cell therapy space and positioned the company as an active contributor to the in vivo CAR-T and RNA delivery fields ahead of its formal launch.
  • Secured and managed a single high-value launch exclusive: Negotiated an exclusive story at Endpoints News for Nava’s first on-the-record feature.
  • Created scalable communications infrastructure including comprehensive PR roadmaps, messaging architecture, and media relations frameworks supporting Formation’s growth toward a portfolio of drug assets.
  • Built and launched Nava’s social and digital presence: Created Nava’s LinkedIn channel and developed a coordinated content strategy spanning corporate, executive, and employee activation — tied to ASGCT, TIDES, BIO 2026, and other conference milestones to sustain momentum across the soft-launch period.